News by subject: HEALTH

The federal Liberal-NDP coalition government recently announced it would work with the provinces to fund universal prescription drug benefits for contraceptives and diabetes medications. It is the first step toward a national pharmacare program that...

Pizza Nova announced today its latest installment in a series of donations to support breakfast programs for Ontario students. On April 12, 2024 Domenic Primucci, President of Pizza Nova, presented the contribution of $28,767 to Student Nutrition...

The rates of precancerous skin conditions and skin cancers are soaring in many parts of the world. Actinic keratosis (AK) is the most common form of precancer, with over 40 million Americans a year developing this condition. Treating AKs before the...

Lophos Holdings Inc. ("Lophos" or the "Company") is delighted to announce the successful receipt of building occupancy for its subsidiary, Lophos Pharmaceuticals Corp., in Napanee, Ontario. This milestone achievement follows the dedicated efforts of...

Khure Health will be presenting at the National Kidney Foundation Spring Clinical Meetings on May 14-18, 2024 in Long Beach, CA.Pentavere will be presenting at the following medical conferences: Canadian Retina Society Annual Meeting on May 3-5,...

Alterity Therapeutics ("Alterity" or...

Diagnos Inc. ("DIAGNOS" or "the Company") , a provider of healthcare services in early detection of certain critical health issues, announces today that it is working on getting new Health Canada and FDA approval on 4 additional AI analysis modules...

Psyence Group Inc ("Psyence Group") , a life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and wellbeing, is pleased to announce that its NASDAQ listed associate, Psyence Biomedical Ltd ("PBM" or...

WHAT:         As the City of Calgary recognizes April 18-24, 2024 as OWN.CANCER week, the Alberta Cancer Foundation, Alberta Health Services and University of Calgary will be hosting a series of fun activations and initiatives across the city to...

PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") , a specialty pharmaceutical company, provides an update of its Priority Original Abbreviated New Drug Application ("ANDA") for Ketamine that was accepted by the U.S. Food and Drug...

Patients are being threatened with extremely long wait times, denied vital procedure information, and coerced or manipulated into paying for unnecessary add-ons at for-profit surgical and diagnostic clinics. The extra charges for medically necessary...

Human Pharma sales up 10.3%* to EUR 20.8 bn, driven by JARDIANCE® and OFEV®Animal Health sales up 6.9 %* to EUR 4.7 bn, fueled by new product launchesR&D expenditures increase by 14.2% to EUR 5.8 bn Boehringer Ingelheim today...

Today, EBC Financial Group (EBC) announced a new partnership with United to Beat Malaria (Beat Malaria), a campaign of the United Nations Foundation (UN Foundation), aimed at protecting those most vulnerable from malaria ? a mosquito-borne disease...

Calgary Health Foundation is pleased to announce the appointment of Rob Peabody as Board Chair. Mr. Peabody most recently served as President and CEO of Husky Energy before its merger with Cenovus Energy. Rob's leadership, demonstrated through his...

This week, LifeLabs joins in celebrating the annual National Medical Laboratory Week, a significant event organized by the Canadian Society for Medical Laboratory Science. This week-long celebration acknowledges and honours the invaluable...

Patients are being threatened with extremely long wait times, denied vital procedure information, and coerced or manipulated into paying for unnecessary add-ons at for-profit surgical and diagnostic clinics. The extra charges for medically necessary...

London Research & Pharmaceuticals has recently publicized data about its lead compound LRP-661 or Cannabidiol sulphate (CBDS), highlighting its safety, efficacy, bioavailability, and predictable PK parameters. CBDS maintains improved oral formulation...

Patients are being threatened with extremely long wait times, denied vital procedure information, and coerced or manipulated into paying for unnecessary add-ons at for-profit surgical and diagnostic clinics. The extra charges for medically necessary...

The Ontario Psychological Association (OPA) today released a pivotal report, "Mental Health in Ontario: Insights from AskForHelpToday.ca," based on an analysis of over 12,000 referrals since the platform's inception in 2021. This comprehensive...

Robotic and endoscopic spine surgeon Dr. Michael Gallizzi has reached yet another milestone in his surgical career, performing his 300th robotic surgery on April 2 in Vail, Colo. It marked the third straight April that Dr. Gallizzi completed a...

The RSC has released its latest report titled "Health Research System Recovery: Strengthening Canada's Health Research System After the COVID-19 Pandemic." The report goes beyond preparing for the next pandemic or health emergency by outlining how to...

Brain Canada and Cassie + Friends are pleased to announce the recipients of the Addressing Mental Health in Paediatric Rheumatic Diseases Team Grants program. This year's awardees are Roberta Berard, from the London Health Science Centre and Mark...

A recent study published by the Canadian Health Policy Institute examined the availability and wait times for access to new drugs, accounting for product launches, marketing authorizations, and insurance coverage under publicly funded drug plans in...

Microbix Biosystems Inc. , a life sciences innovator, manufacturer, and exporter, announces it will be attending and presenting at the Bloom Burton & Co. Healthcare Investor Conference (the "Conference") taking place at the Metro Toronto Convention...

Algernon Pharmaceuticals Inc. (the "Company" or "Algernon") , is pleased to invite investors and other interested parties to participate in an upcoming special CEO interview and Q & A session on April 16th, 2024, at 4 PM ET / 1 PM PT, hosted by...

The Gairdner Foundation is pleased to announce the 2024 Canada Gairdner Award laureates, recognizing some of the world's most significant biomedical and global health research and discoveries. "Canada is a world leader in science and innovation, and...

Avicanna Inc. ("Avicanna" or the "Company") a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce the completion of its observational...

Xenon Pharmaceuticals Inc. , a neurology-focused biopharmaceutical company, today announced that the company will present at the 2024 Bloom Burton & Co. Healthcare Investor Conference taking place April 16-17, 2024. Company Presentation...

100% reduction of target lesions in one melanoma and one pancreatic cancer patient observed among 4 Partial Responses (PR) to date which include 2 of 4 evaluable dose expansion patients and 2 of 2 MSI-H patients Durable stable disease (SD) in 3...

April 10, 2024 Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips' subsidiaries Philips Holding USA and Philips Respironics have now reached final...

100% reduction of target lesions in one melanoma and one pancreatic cancer patient observed among 4 Partial Responses (PR) to date which include 2 of 4 evaluable dose expansion patients and 2 of 2 MSI-H patients Durable stable disease (SD) in 3...

Rakovina Therapeutics Inc. , ("Rakovina" or the "Company"), a biopharmaceutical company dedicated to improving the lives of cancer patients through the development of novel DNA-damage response inhibitor therapeutics, is pleased to announce that...

Bright Peak Therapeutics, a biotechnology company developing multifunctional immunotherapies for cancer and autoimmune disease, today announced the presentation of new data characterizing the mechanisms of action, and potent preclinical antitumor...

Roth IAMS is proud to announce that it has been selected as the new vendor for the Ontario Ministry of Health's Facilities Condition Assessment (FCA), Application Support, Training and Data Transition Program. Under this contract, Roth IAMS will...

 MDNA113 is targeted to the tumor site where it is activated to simultaneously deliver two immunotherapies, an IL-2 superkine and anti-PD1 antibody, to the same cancer fighting immune cells in the tumor micro-environment (TME) to maximize efficacy...

ABC Fitness, the number one tech provider for fitness businesses everywhere, and Fitness World, a leading fitness organization committed to promoting health and wellness in western Canada, have partnered to elevate Fitness World's operational...

Knight Therapeutics Inc. ("Knight"), a leading pan-American (ex-US) specialty pharmaceutical company, announced today that Samira Sakhia, President and Chief Executive Officer, is scheduled to present a corporate update at the Bloom Burton & Co....

Global ASICS study of 26,000 people reaffirms the connection between movement and the mind and uncovers a direct link between teenage physical activity and adult mental wellbeingEach additional year a teenager remains engaged in exercise is...

Novel camptothecin-peptide conjugates are well tolerated and associated with significant tumor regression in colorectal cancer and triple-negative breast cancer xenograft modelsSORT1 gene silencing results in drastic decrease in peptide-drug...

The Canadian Centre on Substance Use and Addiction (CCSA) proudly welcomes Scott Elliott to its Board of the Directors, following a Governor in Council appointment by the Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate...

Savaria Corporation ("Savaria") a global leader in the accessibility industry, today announced it has acquired all the dumbwaiter and material lift assets of D.A. Matot, Inc. ("Matot"). Founded in 1888, Matot has functioned as a family-owned...

Medeloop, a trailblazer platform for clinical research launched in the United States and Canada, is proud to announce a groundbreaking milestone: the use of its innovative generative AI semantic graph platform to support the analysis of a clinical...

Zymeworks Inc. , a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced five presentations including new data...

Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences", HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the National...

Silicon Valley-based Neurotechnology Powerhouse, announced that it launched its non-invasive iBraintm Personal Brain Monitor, in 4 US states on Friday and sold 1.4% of its stock for more than $85 million, valuing the company at over $6 Billion in the...

IntelGenx Corp. (the "Company" or "IntelGenx") today announced that its co-developer, Chemo Research SL, through its agent and affiliate, Xiromed LLC ("Xiromed"), has received a Complete Response Letter ("CRL") from the U.S. Food and Drug...

In a release issued under the same headline on Thursday, April 4, 2024 by NeuroVigil, Inc., please note the contact information should be [email protected]. The corrected release follows: Silicon Valley-based Neurotechnology Powerhouse,...

Silicon Valley-based Neurotechnology Powerhouse, announced that it launched its non-invasive iBraintm Personal Brain Monitor, in 4 US states on Friday and sold 1.4% of its stock for more than $85 million on Saturday, valuing the company at over $6...

Xenon Pharmaceuticals Inc. , a neurology-focused biopharmaceutical company, today announced that the company will present at the 23rd Annual Needham (Virtual) Healthcare Conference taking place April 8-11, 2024. Company Fireside Chat Presentation...

The Canadian Association for Suicide Prevention (CASP) is thrilled to announce the "Inspiring Hope Together" National Suicide Prevention Conference, scheduled to take place from May 29 to May 31, 2024, at the prestigious Pinnacle Hotel Harbourfront...